Defence Therapeutics Inc (QB) (DTCFF)
USOTC
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
The current DTCFF market cap is 30.09M. The company's latest EPS is CAD -0.1485 and P/E is -4.44.
| Year End June 29 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -179k | -974k | -2.97M | -2.37M |
| Net Income | -673k | -2.86M | -7.34M | -6.76M |
| Year End June 29 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 1.91M | 5.61M | 720k | 3.53M |
| Total Liabilities | 48k | 122k | 1.11M | 1.97M |
| Total Equity | 1.86M | 5.49M | -388k | 1.57M |
| Year End June 29 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -133k | -2.29M | -6.04M | -7.66M |
| Investing | -46k | N/A | N/A | -66k |
| Financing | 2.04M | 5.88M | 1.1M | 10.01M |
| Market Cap | 30.09M |
| Price to Earnings Ratio | -4.44 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 10.77 |
| Price to Book Ratio | 19.19 |
| Dividend Yield | - |
| Shares Outstanding | 45.54M |
| Average Volume (1 week) | 1,000 |
| Average Volume (1 Month) | 950 |
| 52 Week Change | -69.72% |
| 52 Week High | 2.50 |
| 52 Week Low | 0.5723 |
| Spread (Intraday) | 0.31 (41.34%) |
| Company Name | Defence Therapeutics Inc (QB) |
| Address |
1680 - 200 burrard street vancouver, british columbia V6C 3L6 |
| Website | https://www.defencetherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
